Source: Contract Pharma

CSafe: CSafe Launches Three New Cold Chain Technologies

Multi-Use Dewars designed to serve cell and gene therapy market, CSafe Connect Control Tower monitoring service, and Silverpod MAX RE.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Patrick Schafer's photo - CEO of CSafe

CEO

Patrick Schafer

CEO Approval Rating

50/100

Read more